CORD presents Rare Disease Drug Strategy Webinars

CORD presents Rare Disease Drug Strategy Webinars

PMPRB: Friend or Foe of Rare Disease Drug Strategy

In February 2019 the federal government committed $1billion over two years starting in 2022 to set up a Canadian Rare Disease Drug Strategy. In August 2019, the government approved regulatory changes to the PMPRB with announced intention to lower drug prices. In theory, are disease drugs would be more accessible. Conversely, pricing could be so severely restricted relative to international norms that many innovative and rare therapies will not be launched in Canada.

On November 6th, Webinar 3 in CORD’s Rare Drug Strategy Consultation, a multi-stakeholder panel will consider the potential impact of the PMPRB revised guidelines on entry and access of rare disease therapies, using “real” case examples. Alternatives will be invited to deliberate on alternatives to the PMPRB guidelines that could better meet the Triple Aim of “timely appropriate patient access”, “optimal, sustainable healthcare expenditure”, and “non-excessive industry compensation that incentivizes launching new therapies and future R&D.”

2020 Consultation Dates
  • Webinar 3: Nov 6 @ 12 pm ET. Addressing individualized needs for rare therapies (Webinar 3 Registration)
  • Webinar 4: Nov 20 @ 12 pm ET. Streamlined rare drug processes across regulatory, HTA, and pricing agencies (Webinar 4 Registration)
  • Webinar 5: Dec 4 @ 12 pm ET. Innovative funding for rare therapies from generic to transformative (Webinar 5 Registration) 


Passed webinar slides can be downloaded here: www.slideshare.net/raredisorders/

Past full webinar are available on CORD's YouTube channel: 

www.youtube.com/user/CORDRareDisorders

 

Back to blog

Leave a public comment:

Please note, comments need to be approved before they are published.

  • Coleen Cunningham Foundation (CCF) Launches Global $10,000 Monthly AdWords Campaign to Boost PSP Awareness

    Coleen Cunningham Foundation (CCF) Launches Glo...

    Laura Louizos

    FOR IMMEDIATE RELEASEColeen Cunningham Foundation (CCF) Launches Global $10,000 Monthly AdWords Campaign to Boost PSP AwarenessOctober 15, 2024 - The Coleen Cunningham Foundation (CCF) is excited to announce the upcoming...

    Coleen Cunningham Foundation (CCF) Launches Glo...

    Laura Louizos

    FOR IMMEDIATE RELEASEColeen Cunningham Foundation (CCF) Launches Global $10,000 Monthly AdWords Campaign to Boost PSP AwarenessOctober 15, 2024 - The Coleen Cunningham Foundation (CCF) is excited to announce the upcoming...

  • The Dual Facets of Love: Sorrow and Strength

    The Dual Facets of Love: Sorrow and Strength

    Laura Louizos

    At 40, life asked me to say goodbye to my mother, the woman who taught me love, patience, and kindness. Five years later, at 45, I stood by my father,...

    The Dual Facets of Love: Sorrow and Strength

    Laura Louizos

    At 40, life asked me to say goodbye to my mother, the woman who taught me love, patience, and kindness. Five years later, at 45, I stood by my father,...

  • The Unseen Journey of Love and Loss

    The Unseen Journey of Love and Loss

    Laura Louizos

    There is a profound silence that fills the room where a loved one passes away—a silence that speaks volumes of the love shared, the battles fought, and the inevitable farewells....

    The Unseen Journey of Love and Loss

    Laura Louizos

    There is a profound silence that fills the room where a loved one passes away—a silence that speaks volumes of the love shared, the battles fought, and the inevitable farewells....

  • Detailed illustration of a human brain with glowing microtubules, interacting with soft blue NIR light, set against a modern, scientific background.

    Advancing Alzheimer's Research: Vielight Techno...

    Laura Louizos

    Vielight's 810nm NIR PBM shows promise in Alzheimer's treatment by enhancing tubulin integrity and reducing neurotoxicity, potentially improving cognitive function and slowing disease progression. Discount Code: PSPAwareness saves 10%

    Advancing Alzheimer's Research: Vielight Techno...

    Laura Louizos

    Vielight's 810nm NIR PBM shows promise in Alzheimer's treatment by enhancing tubulin integrity and reducing neurotoxicity, potentially improving cognitive function and slowing disease progression. Discount Code: PSPAwareness saves 10%

1 of 4